Risk factors for the development of chronic obstructive pulmonary disease

Medical Clinics of North America

Volumn 80, Issue 3, 1996, Pages 501-522

  Silverman, E K ^a   Speizer, F E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIR POLLUTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DIET; GENETIC ANALYSIS; HUMAN; OCCUPATIONAL EXPOSURE; PASSIVE SMOKING; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR;

EID: 0029978363     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70451-X     Document Type: Article

References (74)

1. T.H. Beaty K.Y. Liang S. Seerey Robust inference for variance components models in families ascertained through probands: II. Analysis of spirometric measures Genet Epidemiol 4 1987 211 221
2. E.H. Bel A.H. Zwinderman M.C. Timmers Excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease Thorax 46 1991 9 14
3. L.F. Black F. Kueppers Alpha 1-antitrypsin deficiency in nonsmokers Am Rev Respir Dis 117 1978 421 428
4. M. Brantly T. Nukiwa R.G. Crystal Molecular basis of alpha-1-antitrypsin deficiency Am J Med 84 suppl 6A 1988 13 31
5. J. Britton Dietary fish oil and airways obstruction Thorax 50 suppl 1 1995 S11 S15
6. R.M. Bruce B.H. Cohen E.L. Diamond Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects Am Rev Respir Dis 130 1984 386 390
7. B. Burrows R.J. Knudson M.G. Cline Quantitative relationships between cigarette smoking and ventilatory function Am Rev Respir Dis 115 1977 195 205
8. B. Burrows R.J. Knudson M.G. Cline A reexamination of risk factors for ventilatory impairment Am Rev Respir Dis 138 1988 829 836
9. D.W. Cockcroft The bronchial late response in the pathogenesis of asthma and its modulation by therapy Ann Allergy 55 1985 857 862
10. B.H. Cohen Chronic obstructive pulmonary disease: A challenge in genetic epidemiology Am J Epidemiol 112 1980 274 288
11. B.H. Cohen W.C. Ball Jr S. Brashears Risk factors in chronic obstructive pulmonary disease (COPD) Am J Epidemiol 105 1977 223 232
12. R.G. Crystal M.L. Brantly R.C. Hubbard The alpha 1-antitrypsin gene and its mutations: Clinical consequences and strategies for therapy Chest 95 1989 196 208
13. R.M. Davis T.E. Novotny Changes in risk factors: The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease Am Rev Respir Dis 140 suppl 1989 S82 S84
14. A.G. Davison A.J. Newman Taylor J. Darbyshire Cadmium fume inhalation and emphysema Lancet 1 1988 663 667
15. R. Detels J.W. Sayre A.H. Coulson The UCLA population studies of chronic obstructive respiratory disease: IV. Respiratory effect of long-term exposure to photochemical oxidants, nitrogen dioxide, and sulfates on current and never smokers Am Rev Respir Dis 124 1981 673 680
16. D.W. Dockery F.E. Speizer B.G. Ferris Jr Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults Am Rev Respir Dis 137 1988 286 292
17. M. Dossing J. Khan F. Al-Rabiah Risk factors for chronic obstructive lung disease in Saudi Arabia Respir Med 88 1994 519 522
18. J.I. Du Toit A.J. Woolcock C.M. Salome Characteristics of bronchial hyperresponsiveness in smokers with chronic air-flow limitation Am Rev Respir Dis 134 1986 498 501
19. M. Feinleib H.M. Rosenberg J.G. Collins Trends in COPD morbidity and mortality in the United States Am Rev Respir Dis 140 suppl 1989 S9 S18
20. J.E. Fielding K.J. Phenow Health effects of involuntary smoking N Engl J Med 319 1988 1452 1460
21. P. Fischer B. Remijn B. Brunekreef Indoor air pollution and its effect on pulmonary function of adult non-smoking women: II. Associations between nitrogen dioxide and pulmonary function Int J Epidemiol 14 1985 221 226
22. C. Fletcher R. Peto The natural history of chronic airflow obstruction Br Med J 1 1977 1645 1648
23. C.M. Fletcher R. Peto F.E. Speizer A follow-up study of the natural history of obstructive bronchitis N.G.M. Orie R. Van Der Lende Bronchitis III. Third International Symposium 1970 Royal VanGorcum, Ltd. Assen, The Netherlands 103 116
24. C. Fletcher R. Peto C. Tinker Factors related to the development of airflow obstruction The Natural History of Chronic Bronchitis and Emphysema 1976 Oxford University Press Oxford 70 105
25. 1 decline in male working populations Am Rev Respir Dis 146 1992 878 883
26. D.R. Gold I.B. Tager S.T. Weiss Acute lower respiratory illness in childhood as a predictor of lung function and chronic respiratory symptoms Am Rev Respir Dis 140 1989 877 884
27. J.D. Hackney W.S. Linn E.L. Avol Exposures of older adults with chronic respiratory illness to nitrogen dioxide: A combined laboratory and field study Am Rev Respir Dis 146 1992 1480 1486
28. S. Halken A. Host L. Nilsson Passive smoking as a risk factor for development of obstructive respiratory disease and allergic sensitization Allergy 50 1995 97 105
29. J.P. Hanrahan I.B. Tager M.R. Segal The effect of maternal smoking during pregnancy on early infant lung function Am Rev Respir Dis 145 1992 1129 1135
30. E. Hnizdo Combined effect of silica dust and tobacco smoking on mortality from chronic obstructive lung disease in gold miners Br J Ind Med 47 1990 656 664
31. W.W. Holland D.D. Reid The urban factor in chronic bronchitis Lancet 1 1965 445 448
32. A. Janoff Elastases and emphysema: Current assessment of the protease-antiprotease hypothesis Am Rev Respir Dis 132 1985 417 433
33. E.D. Janus Alpha 1-antitrypsin Pi types in COPD patients Chest 94 1988 446 447
34. E.D. Janus N.T. Phillips R.W. Carrell Smoking, lung function, and alpha 1-antitrypsin deficiency Lancet 1 1985 152 154
35. R.E. Kanner A.D. Renzetti Jr M.R. Klauber Variables associated with changes in spirometry in patients with obstructive lung diseases Am J Med 67 1979 44 50
36. K.D. Kochanek B.L. Hudson Advance report of final mortality statistics, 1992 Monthly Vital Statistics Report 43 1995 1 73
37. R.J. Korn D.W. Dockery F.E. Speizer Occupational exposures and chronic respiratory symptoms: A population-based study Am Rev Respir Dis 136 1987 298 304
38. F. Kueppers R.D. Miller H. Gordon Familial prevalence of chronic obstructive pulmonary disease in a matched pair study Am J Med 63 1977 336 342
39. P. Lange J. Nyboe M. Appleyard Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes Thorax 45 1990 579 585
40. R.K. Larson M.L. Barman F. Kueppers Genetic and environmental determinants of chronic obstructive pulmonary disease Ann Intern Med 72 1970 627 632
41. C. Larsson Natural history and life expectancy in severe alpha 1-antitrypsin deficiency, Pi Z Acta Med Scand 204 1978 345 351
42. C. Larsson S. Eriksson H. Dirksen Smoking and intermediate alpha 1-antitrypsin deficiency and lung function in middle-aged men Br Med J 2 1977 922 925
43. F.I. Lewitter I.B. Tager M. McGue Genetic and environmental determinants of level of pulmonary function Am J Epidemiol 120 1984 518 529
44. J. Lieberman B. Winter A. Sastre Alpha 1-antitrypsin Pi-types in 965 COPD patients Chest 89 1986 370 373
45. S.L. Mann M.E.J. Wadsworth J.R.T. Colley Accumulation of factors influencing respiratory illness in members of a national birth cohort and their offspring J Epidemiol Commun Health 46 1992 286 292
46. M.A. Masi J.A. Hanley P. Ernst Environmental exposure to tobacco smoke and lung function in young adults Am Rev Respir Dis 138 1988 296 299
47. M.-R. Masjedi H. Kazemi D.C. Johnson Effects of passive smoking on the pulmonary function of adults Thorax 45 1990 27 31
48. D.E. Niewoehner Cigarette smoking, lung inflammation, and the development of emphysema J Lab Clin Med 111 1988 15 27
49. P.M. O'Byrne J. Dolovich F.E. Hargreave Late asthmatic responses Am Rev Respir Dis 136 1987 740 751
50. G.T. O'Connor D. Sparrow M. Segal Risk factors for ventilatory impairment among middle-aged and elderly men: The Normative Aging Study Chest 103 1993 376 382
51. G.T. O'Connor D. Sparrow S.T. Weiss The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease Am Rev Respir Dis 140 1989 225 252
52. G.T. O'Connor D. Sparrow S.T. Weiss A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: The Normative Aging Study Am J Respir Crit Care Med 152 1995 87 92
53. Official Statement of the American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma Am Rev Respir Dis 136 1987 225 244
54. N.G.M. Orie H.J. Sluiter K. de Vries The host factor in bronchitis N.G.M. Orie H.J. Sluiter Bronchitis 1961 Royal VanGorcum, Ltd. Assen, The Netherlands 43 59
55. A.D. Oxman D.C.F. Muir H.S. Shannon Occupational dust exposure and chronic obstructive pulmonary disease: A systematic overview of the evidence Am Rev Respir Dis 148 1993 38 48
56. M.R. Pandey Domestic smoke pollution and chronic bronchitis in a rural community of the Hill Region of Nepal Thorax 39 1984 337 339
57. R. Peto F.E. Speizer A.L. Cochrane The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease Am Rev Respir Dis 128 1983 491 560
58. S. Redline P.V. Tishler B. Rosner Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins Am J Epidemiol 129 1989 827 836
59. 1 Am J Respir Crit Care Med 151 1995 1377 1382
60. B.A. Rybicki T.H. Beaty B.H. Cohen Major genetic mechanisms in pulmonary function J Clin Epidemiol 43 1990 667 675
61. J.M. Samet I.B. Tager F.E. Speizer The relationship between respiratory illness in childhood and chronic air-flow obstruction in adulthood Am Rev Respir Dis 127 1983 508 523
62. E. Shahar A.R. Folsom S.L. Melnick Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease N Engl J Med 331 1994 228 233
63. S.O. Shaheen D.J.P. Barker A.W. Shiell The relationship between pneumonia in early childhood and impaired lung function in late adult life Am J Respir Crit Care Med 149 1994 616 619
64. E.K. Silverman J.A. Pierce M.A. Province Variability of pulmonary function in alpha 1-antitrypsin deficiency: Clinical correlates Ann Intern Med 111 1989 982 991
65. E.K. Silverman M.A. Province E.J. Campbell Variability of pulmonary function in alpha-1-antitrypsin deficiency: Residual family resemblance beyond the effect of the Pi locus Hum Hered 40 1990 340 355
66. E.K. Silverman M.A. Province D.C. Rao A family study of the variability of pulmonary function in alpha 1-antitrypsin deficiency: Quantitative phenotypes Am Rev Respir Dis 142 1990 1015 1021
67. H.J. Sluiter G.H. Koeter J.G.R. de Monchy The Dutch Hypothesis (chronic nonspecific lung disease) revisited Eur Respir J 4 1991 479 489
68. G.L. Snider Changes in COPD occurrence: Chronic obstructive pulmonary disease: A definition and implications of structural determinants of airflow obstruction for epidemiology Am Rev Respir Dis 140 suppl 1989 S3 S8
69. I.B. Tager S.T. Weiss A. Munoz Longitudinal study of the effects of maternal smoking on pulmonary function in children N Engl J Med 309 1983 699 703
70. M.J. Tobin P.J.L. Cook D.C.S. Hutchison Alpha 1-antitrypsin deficiency: The clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z Br J Dis Chest 77 1983 14 27
71. J. Travis G.S. Salvesen Human plasma proteinase inhibitors Ann Rev Biochem 52 1983 655 709
72. U.S. Public Health Service: Smoking and health: Report of the advisory committee to the Surgeon General of the Public Health Service. U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, PHS Publication No. 1103, 1964
73. C.P. van Schayck E. Dompeling J. Molema Does bronchial hyperresponsiveness precede or follow airway obstruction in asthma or COPD? Neth J Med 45 1994 145 153
74. M.T.A. Villar L. Dow D. Coggon The influence of increased bronchial responsiveness, atopy, and serum IgE on decline in FEV1: A longitudinal study in the elderly Am J Respir Crit Care Med 151 1995 656 662